In a 12-month clinical trial involving 404 HIV-infected patients with excess abdominal fat, Tesamorelin (2 mg daily) significantly reduced visceral adipose tissue (VAT) compared to placebo
The highly anticipated phase 3 EVOKE trial readout found that semaglutide did not significantly reduce progression of Alzheimer's disease
Tesamorelin may help by: Supporting fat metabolism , particularly visceral fat in some individuals Supporting healthy IGF-1 signaling (within appropriate clinical oversight) Potentially improving body composition when paired with lifestyle habits Supporting overall metabolic function Ipamorelin may help by: Supporting restorative sleep (which impacts hormones, hunger, and recovery) Supporting muscle recovery and training adaptation Promoting growth hormone release with a profile many clients tolerate well Supporting overall recovery capacity when paired with training or busy lifestyles In simpler terms: Tesamorelin is often chosen for metabolism and stubborn midsection support , while Ipamorelin is commonly used for sleep and recovery
Well work with you to find protein sources that work for your body, whether thats grass-fed meats, wild-caught fish, pastured eggs, dairy (if you tolerate it), or plant-based options that align with your values and digestive capacity
Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis
Additionally, GLP-1 RAs may reduce -cell apoptosis, further contributing to the risk of neoplastic transformation [27]
